AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2016

Jan 5, 2016

31802_dirs_2016-01-05_ecac4a68-b667-4866-9b49-cb50bc43ff2d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2015-12-28

Reporting Person: LUX ANDREW L (SVP, Ops & Quality)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-12-28	Common Stock	F	799	$22.53	Disposed	40919	Direct
2015-12-31	Common Stock	A	326	$19.07	Acquired	41245	Direct

Footnotes

F1: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award.

F2: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 31, 2015.

F3: Closing price on December 31, 2015 was $22.44.